Literature DB >> 7701050

Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors.

M Kathmann1, E Schlicker, M Göthert.   

Abstract

It was the aim of the present study to determine the affinities of four neuroleptics and five antidepressants for histamine H3 receptors. In rat brain cortex membranes, the specifically bound [3H]-N alpha-methylhistamine was monophasically displaced by clozapine (pKi 6.15). The other drugs did not completely displace the radioligand even at 100 microM; the pKi values were: haloperidol (4.91); sulpiride (4.73); amitriptyline (4.56); desipramine (4.15); levomepromazine (4.14); fluovoxamine (4.13); maprotiline (4.09); moclobemide (< 4.0). The effect of clozapine was further examined in a functional H3 receptor model, i.e., in superfused mouse brain cortex slices preincubated with [3H]-noradrenaline. The electrically evoked tritium overflow was not affected by clozapine 0.5-32 microM. However, clozapine shifted the concentration-response curve of histamine for its inhibitory effect on the evoked overflow to the right, but did not affect the maximum effect of histamine. The Schild plot yielded a pA2 value of 6.33. In conclusion, clozapine shows an intermediate affinity and potency (as a competitive antagonist) at H3 receptors. The Ki value of clozapine at H3 receptors resembles its Ki value at D2 receptors (the target of the classical neuroleptics), but is higher than its Ki values at D4, 5-HT2 or muscarinic acetylcholine receptors, which according to current hypotheses, might be involved in the atypical profile of clozapine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7701050     DOI: 10.1007/BF02247479

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

Review 1.  The histamine H3-receptor: a target for developing new drugs.

Authors:  R Leurs; H Timmerman
Journal:  Prog Drug Res       Date:  1992

2.  Mutual interaction of histamine H3-receptors and alpha 2-adrenoceptors on noradrenergic terminals in mouse and rat brain cortex.

Authors:  E Schlicker; A Behling; G Lümmen; B Malinowska; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

3.  Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells.

Authors:  C Bolden; B Cusack; E Richelson
Journal:  Eur J Pharmacol       Date:  1991-01-03       Impact factor: 4.432

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Analysis of dose-response curves and calculation of agonist dissociation constants using a weighted nonlinear curve fitting program.

Authors:  G A McPherson; P Molenaar; C Raper; E Malta
Journal:  J Pharmacol Methods       Date:  1983-12

Review 6.  The classification of drugs and drug receptors in isolated tissues.

Authors:  T P Kenakin
Journal:  Pharmacol Rev       Date:  1984-09       Impact factor: 25.468

Review 7.  Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.

Authors:  P Seeman
Journal:  Neuropsychopharmacology       Date:  1992-12       Impact factor: 7.853

8.  Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models.

Authors:  E Schlicker; M Kathmann; S Reidemeister; H Stark; W Schunack
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

9.  Nordimaprit, homodimaprit, clobenpropit and imetit: affinities for H3 binding sites and potencies in a functional H3 receptor model.

Authors:  M Kathmann; E Schlicker; M Detzner; H Timmerman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

10.  Pharmacological activity of VUF 9153, an isothiourea histamine H3 receptor antagonist.

Authors:  J C Barnes; J D Brown; N P Clarke; J Clapham; D J Evans; C T O'Shaughnessy
Journal:  Eur J Pharmacol       Date:  1993-11-30       Impact factor: 4.432

View more
  9 in total

1.  The moderate affinity of clozapine at H3 receptors is not shared by its two major metabolites and by structurally related and unrelated atypical neuroleptics.

Authors:  E Schlicker; I Marr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

Review 2.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 3.  An update on histamine H3 receptors and gastrointestinal functions.

Authors:  G Bertaccini; G Coruzzi
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

4.  Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo.

Authors:  Marie Humbert-Claude; Elisabeth Davenas; Florence Gbahou; Ludwig Vincent; Jean-Michel Arrang
Journal:  Psychopharmacology (Berl)       Date:  2011-09-13       Impact factor: 4.530

5.  Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity?

Authors:  E Schlicker; M Kathmann; H Bitschnau; I Marr; S Reidemeister; H Stark; W Schunack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

6.  Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors.

Authors:  M Kathmann; E Schlicker; M Göthert
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

7.  Altered histamine H3 receptor radioligand binding in post-mortem brain samples from subjects with psychiatric diseases.

Authors:  C Y Jin; O Anichtchik; P Panula
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

Review 8.  Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).

Authors:  H Bönisch; K B Fink; B Malinowska; G J Molderings; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-15       Impact factor: 3.000

9.  Non-Imidazole Histamine H₃ Ligands. Part VII. Synthesis, In Vitro and In Vivo Characterization of 5-Substituted-2-thiazol-4-n-propylpiperazines.

Authors:  Roman Guryn; Marek Staszewski; Anna Stasiak; Daniel McNaught Flores; Wiesława Agnieszka Fogel; Rob Leurs; Krzysztof Walczyński
Journal:  Molecules       Date:  2018-02-03       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.